# Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use

> **NCT00430573** · PHASE2 · TERMINATED · sponsor: **Boston University Charles River Campus** · enrollment: 15 (actual)

## Conditions studied

- Substance-Related Disorders

## Interventions

- **DRUG:** D-cycloserine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00430573
- **Lead sponsor:** Boston University Charles River Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-02
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** The investigators failed to recruit participants as originally projected.
- **Last updated:** 2018-05-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00430573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00430573, "Efficacy of D-Cycloserine for Enhancing the Effects of CBT for Substance Use". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00430573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*